NATURE’S SUNSHINE PRODUCTS, INC. Dividends Payable, Current
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) had Dividends Payable, Current of $19.86 million as of 2021-03-31, per its 10-Q filed 2021-05-06.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DividendsPayableCurrent · last filed 2021-05-06
- 2021-03-31: Dividends Payable, Current $19.86M.
- 2020-12-31: Dividends Payable, Current $0.00.
| Period end | Dividends Payable, Current |
|---|---|
| 2021-03-31 | $19.86M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $0.00 10-Q · filed 2021-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |